Unknown

Dataset Information

0

A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients.

ABSTRACT:

SUBMITTER: Alwhaibi A 

PROVIDER: S-EPMC11765622 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients.

Alwhaibi Abdulrahman A   Alenazi Miteb A MA   Alghadeer Sultan S   Mansy Wael W   Alsaif Reem A RA   Abualreesh Nawaf E NE   Alanazi Rakan J RJ   Alroumi Abdullah A   Alanazi Saleh A SA  

Journal of clinical medicine 20250109 2

<b>Background/Objectives:</b> Owing to the growing use of immune checkpoint inhibitors (ICIs) in the treatment of cancer, a wide spectrum of toxicity has arisen among cancer patients. Yet, limited ICI toxicity-related research is currently conducted in our region. <b>Methods:</b> This is a retrospective observational study conducted on adult cancer patients who received at least one cycle of ICI single therapy. Toxicity profiles of different ICI monotherapies were described and compared, and the  ...[more]

Similar Datasets

Unknown Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data.
| S-EPMC10486692 | biostudies-literature
Unknown Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study.
| S-EPMC10774961 | biostudies-literature
Unknown Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world.
| S-EPMC11001672 | biostudies-literature
Unknown A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors.
| S-EPMC12606222 | biostudies-literature
Unknown Effectiveness and Safety of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review of Real-World Studies.
| S-EPMC12227369 | biostudies-literature
Unknown Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study.
| S-EPMC10991115 | biostudies-literature
Unknown Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma.
| S-EPMC6826482 | biostudies-literature
Unknown Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.
| S-EPMC8964934 | biostudies-literature
Unknown Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma.
| S-EPMC11921401 | biostudies-literature
Unknown Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study.
| S-EPMC9974953 | biostudies-literature